ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

CYSTAGON
Miscellaneous urogenital disorders
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

CYSTAGON Rx

Generic Name and Formulations:
Cysteamine bitartrate 50mg, 150mg; caps.

Company:
Mylan Inc.

Therapeutic Use:

Indications for CYSTAGON:

Management of nephropathic cystinosis.

Adult:

New patients: start on ¼ to ⅙ of the maintenance dose; increase gradually over 4–6 weeks. Maintenance: >12yrs and >110lbs: 2g/day divided 4 times daily. Max 1.95g/m2/day. Goal of therapy to keep leukocyte cystine levels below 1nmol/½ cystine/mg protein 5–6 hours after administration. Patients taking cysteamine HCl or phosphocysteamine solutions may be transferred to equimolar doses of cysteamine bitartrate.

Children:

1.3g/m2/day in 4 divided doses. Max 1.95g/m2/day. If <6yrs old: do not give intact caps; may open and sprinkle capsule contents over food.

Contraindications:

Penicillamine hypersensitivity.

Warnings/Precautions:

Withhold dose if skin rash develops, may be restarted at a lower dose then titrated slowly; if severe, do not readminister. Monitor blood counts, LFTs, vision, skin, bones. Measure leukocyte cystine levels every 3 months, more frequently when transferring from cysteamine HCl or phosphocysteamine solutions. Pregnancy (Cat.C). Nursing mothers: not recommended.

Pharmacological Class:

Cystine-depleting agent.

Adverse Reactions:

Vomiting, anorexia, fever, diarrhea, lethargy, rash; skin or bone lesions (reduce dose if appears), leukopenia, abnormal LFTs, CNS effects, GI ulceration/bleeding, pseudotumor cerebri, papilledema; rare: interstitial nephritis with early renal failure.

How Supplied:

Caps—500

Sign Up for Free e-newsletters